SFMBT1 and bone neoplasm: We also tested Ru1 in a PDX model of osteosarcoma (OS), the most common primary bone tumor in children and adolescents and a tumor where CSCs are believed to drive metastasis and contribute to poor prognosis in advanced OS patients [49].